Raymond Dwek United Therapeutics Corp (UTHR) insider trading activity

Raymond Dwek is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 1,750 shares of UTHR, which is worth approximately $631,522. The most recent transaction as insider was on Aug 02, 2024, when has been sold 5,000 shares (Common Stock) at a price of $325.9 per share, resulting in proceeds of $1,629,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.75K

0% 3M change

0% 12M change

Total Value Held $631,522

RAYMOND DWEK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2024	SELL Open market or private sale	$1,629,500 $325.9 p/Share	5,000 Reduced 74.07%	1,750 Common Stock
Aug 02 2024	BUY Exercise of conversion of derivative security	$877,150 $175.43 p/Share	5,000 Added 42.55%	6,750 Common Stock
Apr 22 2024	SELL Sale (or disposition) back to the issuer	$702,180 $234.06 p/Share	3,000 Reduced 63.16%	1,750 Common Stock
Apr 22 2024	BUY Exercise of conversion of derivative security	$264,090 $88.03 p/Share	3,000 Added 38.71%	4,750 Common Stock
Apr 15 2024	SELL Sale (or disposition) back to the issuer	$705,240 $235.08 p/Share	3,000 Reduced 63.16%	1,750 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	$264,090 $88.03 p/Share	3,000 Added 38.71%	4,750 Common Stock
Apr 08 2024	SELL Sale (or disposition) back to the issuer	$947,840 $236.96 p/Share	4,000 Reduced 69.57%	1,750 Common Stock
Apr 08 2024	BUY Exercise of conversion of derivative security	$352,120 $88.03 p/Share	4,000 Added 41.03%	5,750 Common Stock
Jul 07 2023	BUY Exercise of conversion of derivative security	-	1,750 Added 50.0%	1,750 Common Stock
Apr 21 2023	SELL Sale (or disposition) back to the issuer	$461,520 $230.76 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 21 2023	BUY Exercise of conversion of derivative security	$127,800 $63.9 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 14 2023	SELL Sale (or disposition) back to the issuer	$457,440 $228.72 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 14 2023	BUY Exercise of conversion of derivative security	$127,800 $63.9 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 10 2023	SELL Sale (or disposition) back to the issuer	$669,210 $223.07 p/Share	3,000 Reduced 100.0%	0 Common Stock
Apr 10 2023	BUY Exercise of conversion of derivative security	$191,700 $63.9 p/Share	3,000 Added 50.0%	3,000 Common Stock
Nov 07 2022	SELL Sale (or disposition) back to the issuer	$1,334,000 $266.8 p/Share	5,000 Reduced 100.0%	0 Common Stock
Nov 07 2022	BUY Exercise of conversion of derivative security	$440,150 $88.03 p/Share	5,000 Added 50.0%	5,000 Common Stock
Sep 09 2022	SELL Sale (or disposition) back to the issuer	$670,440 $223.48 p/Share	3,000 Reduced 100.0%	0 Common Stock
Sep 09 2022	BUY Exercise of conversion of derivative security	$191,700 $63.9 p/Share	3,000 Added 50.0%	3,000 Common Stock
Jul 11 2022	SELL Open market or private sale	$521,186 $241.29 p/Share	2,160 Reduced 100.0%	0 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	-	2,160 Added 50.0%	2,160 Common Stock
May 26 2022	SELL Sale (or disposition) back to the issuer	$1,123,900 $224.78 p/Share	5,000 Reduced 71.43%	2,000 Common Stock
May 26 2022	BUY Exercise of conversion of derivative security	$319,500 $63.9 p/Share	5,000 Added 41.67%	7,000 Common Stock
May 05 2022	SELL Sale (or disposition) back to the issuer	$373,980 $186.99 p/Share	2,000 Reduced 100.0%	0 Common Stock
May 05 2022	BUY Exercise of conversion of derivative security	$96,220 $48.11 p/Share	2,000 Added 50.0%	2,000 Common Stock

Raymond Dwek

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account